ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
Public ClinicalTrials.gov record NCT00981617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Adaptive Study of the Safety and Efficacy of RDC-0313 in Adults With Alcohol Dependence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and efficacy of ALKS33 (RDC-0313) compared with placebo in adults with alcohol dependence. There will be 11 study visits conducted over a period of about 4 months. The study period includes a screening visit, a 12-week treatment period, and a follow-up visit.
Study identification
- NCT ID
- NCT00981617
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 406 participants
Conditions and interventions
Conditions
Interventions
- ALKS33 (RDC-0313) (1 mg) Drug
- ALKS33 (RDC-0313) (2.5 mg) Drug
- ALKS33 (RDC-0313) (10 mg) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2009 (Type not available)
- Primary completion
- Aug 2010 (Actual)
- Completion
- Aug 2010 (Actual)
- Last update posted
- Aug 23, 2011
2009 – 2010
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Tucson | Arizona | 85712 | — |
| Alkermes Investigational Site | Cerritos | California | 90703 | — |
| Alkermes Investigational Site | Oceanside | California | 92056 | — |
| Alkermes Investigational Site | Pico Rivera | California | 90660 | — |
| Alkermes Investigational Site | San Diego | California | 92102 | — |
| Alkermes Investigational Site | Jacksonville | Florida | 32216 | — |
| Alkermes Investigational Site | Maitland | Florida | 32751 | — |
| Alkermes Investigational Site | Orlando | Florida | 32806 | — |
| Alkermes Investigational Site | South Miami | Florida | 33143 | — |
| Alkermes Investigational Site | West Palm Beach | Florida | 33407 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30320 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30328 | — |
| Alkermes Investigational Site | Roswell | Georgia | 30076 | — |
| Alkermes Investigational Site | Lafayette | Indiana | 47905 | — |
| Alkermes Investigational Site | Fall River | Massachusetts | 02720 | — |
| Alkermes Investigational Site | Las Vegas | Nevada | 89146 | — |
| Alkermes Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Alkermes Investigational Site | Brooklyn | New York | 11235 | — |
| Alkermes Investigational Site | New York | New York | 10010 | — |
| Alkermes Investigational Site | Charlotte | North Carolina | 28209 | — |
| Alkermes Investigational site | Hickory | North Carolina | 28601 | — |
| Alkermes Investigational Site | New Bern | North Carolina | 28562 | — |
| Alkermes Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Alkermes Investigational Site | Philadelphia | Pennsylvania | 19118 | — |
| Alkermes Investigational Site | Houston | Texas | 77090 | — |
| Alkermes Investigational Site | Salt Lake City | Utah | 84107 | — |
| Alkermes Investigational Site | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00981617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00981617 live on ClinicalTrials.gov.